Effect of thiamine pyrophosphate on ischemia-reperfusion induced oxidative damage in rat kidney. 2013

Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
Department of Pharmacology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey.

OBJECTIVE The biochemical effects of thiamine pyrophosphate on ischemia-reperfusion (IR) induced oxidative damage and DNA mutation in rat kidney tissue were investigated, and compared to thiamine. METHODS Rats were divided into four groups: renal ischemia-reperfusion (RIR); thiamine pyrophosphate + RIR (TPRIR); thiamine + RIR (TRIR); and sham group (SG). RESULTS The results of biochemical experiments have shown that malondialdehyde (MDA) levels in rat kidney tissue after TRIR and TPRIR treatment were 7.2 ± 0.5 (P > 0.05) and 3.3 ± 0.3 (P < 0.0001) μmol/g protein, respectively. The MDA levels in the SG rat kidney tissue and in RIR group were 3.6 ± 0.2 (P < 0.0001) and 7.6 ± 0.6 μmol/g protein, respectively. Total glutathione (tGSH) levels in TRIR, TPRIR, SG, and RIR animal groups were 2.2 ± 0.3 (P > 0.05), 5.8 ± 0.4 (P < 0.0001), 6.2 ± 0.2 (P < 0.0001), and 1.7 ± 0.2 nmol/g protein, respectively. In the TRIR, TPRIR, SG, and RIR animal groups; 8-hydroxyguanine (8-OHGua)/Gua levels, which indicate mutagenic DNA, were 1.75 ± 0.12 (P > 0.05), 0.93 ± 0.1 (P < 0.0001), 0.85 ± 0.08 (P < 0.0001), and 1.93 ± 0.24 pmol/L, respectively. CONCLUSIONS It has been shown that thiamine pyrophosphate prevents increase in mutagenic DNA in IR induced oxidative damage, whereas thiamine does not have this effect.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006147 Guanine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013835 Thiamine Pyrophosphate The coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the PYRUVATE DEHYDROGENASE COMPLEX and the KETOGLUTARATE DEHYDROGENASE COMPLEX. Cocarboxylase,Thiamine Diphosphate,Berolase,Pyrophosphate, Thiamine
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
December 2014, Iranian journal of basic medical sciences,
Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
January 2012, Renal failure,
Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
January 2013, BioMed research international,
Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
December 2010, The Journal of surgical research,
Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
January 2014, Human & experimental toxicology,
Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
February 2022, Advances in clinical and experimental medicine : official organ Wroclaw Medical University,
Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
August 2016, Renal failure,
Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
August 2020, Life sciences,
Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
September 2002, Transplantation proceedings,
Durdu Altuner, and Nihal Cetin, and Bahadir Suleyman, and Zeynep Aslan, and Ahmet Hacimuftuoglu, and Mine Gulaboglu, and Neslihan Isaoglu, and Ismail Demiryilmaz, and Halis Suleyman
March 2003, European journal of pharmacology,
Copied contents to your clipboard!